grant
Narodni ustav dusevniho zdraviEuropean Commission
- Acquirer or investor
- European Commission
- Upfront
- $0.22m
- Contingent
- Not disclosed
- Headline total
- $0.22m
- Currency
- EUR 191918.16 EU contribution
- Status
- active
- Close date
- Not disclosed
- Geography
- CZ
- Lead asset
- none (preclinical circuitry research, psychedelics unspecified)
- Phase
- preclinical
- Indication
- not applicable
Structure
Horizon Europe MSCA grant agreement 101210911, project PsyHab: Investigating the effects of psychedelics on Lateral Habenula-Dorsal Raphe Nuclei circuitry. EU contribution EUR 191,918.16, total cost EUR 191,918.16 as published on CORDIS. Signature date 14 April 2025; start date 1 September 2026; end date 31 August 2028. USD figure converted at the ECB euro reference rate of 25 September 2026, USD 1.1403 per EUR, the latest published on 28 September 2026: EUR 191,918.16 = USD 218,844, stored as 0.22 in the _usd_m columns. Funder recorded as the European Commission; the programme is Horizon Europe, Marie Sklodowska-Curie Actions.
Why it matters
A European public grant with a September 2026 start date, the only European psychedelic financing found with a primary source in the 21 to 28 September window.
Sourcing
- Source type
- cordis
- Verified
- 28 September 2026
- Confidence
- verified